WallStreetZenWallStreetZen

NYSEMKT: CATX
Perspective Therapeutics Inc Stock Ownership - Who owns Perspective Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Perspective Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jonathan Robert HuntChief Accounting Officer2025-11-1311,000$2.03
$22.30kBuy
Robert F. Williamson IiiDirector2025-11-129,498$2.10
$19.95kBuy

1 of 1

CATX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CATX insiders and whales buy or sell their stock.

CATX Shareholders

What type of owners hold Perspective Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lantheus Alpha Therapy LLC102.39%116,773,394$344.48MInsider
Avidity Partners Management LP10.61%12,099,998$35.69MInstitution
Tcg Crossover Management LLC6.94%7,915,567$23.35MInstitution
Commodore Capital LP5.56%6,336,782$18.69MInstitution
Blackrock Inc4.69%5,348,561$15.78MInstitution
Opaleye Management Inc4.10%4,675,000$13.79MInstitution
Vanguard Capital Management LLC3.84%4,378,956$12.92MInstitution
Millennium Management LLC3.55%4,046,640$11.94MInstitution
Citadel Advisors LLC3.13%3,566,504$10.52MInstitution
Affinity Asset Advisors LLC2.77%3,164,582$9.34MInstitution

1 of 3

CATX vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CATX41.47%58.53%Net Buying
CV7.99%17.75%Net BuyingNet Buying
ELMD34.13%65.87%Net SellingNet Selling
MASS51.41%48.59%Net SellingNet Selling
SENS4.61%95.39%Net SellingNet Buying
View Top Medical Device Stocks

Perspective Therapeutics Stock Ownership FAQ

Who owns Perspective Therapeutics?

Perspective Therapeutics (NYSEMKT: CATX) is owned by 75.38% institutional shareholders, 106.39% Perspective Therapeutics insiders, and 0.00% retail investors. Lantheus Alpha Therapy LLC is the largest individual Perspective Therapeutics shareholder, owning 116.77M shares representing 102.39% of the company. Lantheus Alpha Therapy LLC's Perspective Therapeutics shares are currently valued at $346.82M.

If you're new to stock investing, here's how to buy Perspective Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.